Recent breakthroughs in the field of obesity treatment have generated a novel drug known as ALLUVI Retatrutide. This substance is a {highlypotent GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown significant efficacy in clinical trials, highlighting significant decreases in body we